103 related articles for article (PubMed ID: 15991444)
21. Meeting the challenges of interpreting variants of unknown clinical significance in BRCA testing.
Lattimore V; Currie M; Lintott C; Sullivan J; Robinson BA; Walker LC
N Z Med J; 2015 Aug; 128(1419):56-61. PubMed ID: 26365847
[TBL] [Abstract][Full Text] [Related]
22. US panel rejects routine use of BRCA cancer screening in women.
McCarthy M
BMJ; 2013 Apr; 346():f2160. PubMed ID: 23558348
[No Abstract] [Full Text] [Related]
23. FDA to regulate direct-to-consumer genetic tests.
Brower V
J Natl Cancer Inst; 2010 Nov; 102(21):1610-2, 1617. PubMed ID: 20966430
[No Abstract] [Full Text] [Related]
24. Issues of concern in risk assessment, genetic counseling, and genetic testing of younger breast cancer patients in Japan.
Bando H
Breast Cancer; 2014 Nov; 21(6):656-63. PubMed ID: 23754181
[TBL] [Abstract][Full Text] [Related]
25. Pretest genetic counseling informs patients with BRCA mutation.
Printz C
Cancer; 2012 Dec; 118(24):6017. PubMed ID: 23208671
[No Abstract] [Full Text] [Related]
26. Update on the Manchester Scoring System for BRCA1 and BRCA2 testing.
Evans DG; Lalloo F; Wallace A; Rahman N
J Med Genet; 2005 Jul; 42(7):e39. PubMed ID: 15994864
[No Abstract] [Full Text] [Related]
27. Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations.
Lawrence WF; Peshkin BN; Liang W; Isaacs C; Lerman C; Mandelblatt JS
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):475-81. PubMed ID: 11352857
[TBL] [Abstract][Full Text] [Related]
28. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
[TBL] [Abstract][Full Text] [Related]
29. Assessing the knowledge and attitudes regarding genetic testing for breast cancer risk in our region of southeastern Georgia.
MacNew HG; Rudolph R; Brower ST; Beck AN; Meister EA
Breast J; 2010; 16(2):189-92. PubMed ID: 20030654
[TBL] [Abstract][Full Text] [Related]
30. Theory development from studies with young women with breast cancer who are BRCA mutation negative.
Hamilton R; Kopin S
ANS Adv Nurs Sci; 2013; 36(2):E41-53. PubMed ID: 23644270
[TBL] [Abstract][Full Text] [Related]
31. High-risk women should have BRCA testing.
Cancer Discov; 2014 Feb; 4(2):139. PubMed ID: 24501290
[TBL] [Abstract][Full Text] [Related]
32. BRCA testing of breast cancer patients: medical specialists' referral patterns, knowledge and attitudes to genetic testing.
Van Riel E; Wárlám-Rodenhuis CC; Verhoef S; Rutgers EJ; Ausems MG
Eur J Cancer Care (Engl); 2010 May; 19(3):369-76. PubMed ID: 19659662
[TBL] [Abstract][Full Text] [Related]
33. Breast Cancer Risk Assessment: Moving Beyond BRCA 1 and 2.
Scalia-Wilbur J; Colins BL; Penson RT; Dizon DS
Semin Radiat Oncol; 2016 Jan; 26(1):3-8. PubMed ID: 26617204
[TBL] [Abstract][Full Text] [Related]
34. Disparities in BRCA testing: when insurance coverage is not a barrier.
Olaya W; Esquivel P; Wong JH; Morgan JW; Freeberg A; Roy-Chowdhury S; Lum SS
Am J Surg; 2009 Oct; 198(4):562-5. PubMed ID: 19800469
[TBL] [Abstract][Full Text] [Related]
35. Patient satisfaction and cancer-related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2.
Metcalfe KA; Poll A; Llacuachaqui M; Nanda S; Tulman A; Mian N; Sun P; Narod SA
Clin Genet; 2010 Nov; 78(5):411-7. PubMed ID: 20653694
[TBL] [Abstract][Full Text] [Related]
36. Referral and experience with genetic testing among women with early onset breast cancer.
Brown KL; Hutchison R; Zinberg RE; McGovern MM
Genet Test; 2005; 9(4):301-5. PubMed ID: 16379543
[TBL] [Abstract][Full Text] [Related]
37. Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.
Ann Intern Med; 2014 Feb; 160(4):I-16. PubMed ID: 24366402
[No Abstract] [Full Text] [Related]
38. Supreme Court ruling broadens BRCA testing options.
Azvolinsky A
J Natl Cancer Inst; 2013 Nov; 105(22):1671-2. PubMed ID: 24198329
[No Abstract] [Full Text] [Related]
39. Categorizing genetic tests to identify their ethical, legal, and social implications.
Burke W; Pinsky LE; Press NA
Am J Med Genet; 2001; 106(3):233-40. PubMed ID: 11778984
[TBL] [Abstract][Full Text] [Related]
40. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.
Scheuer L; Kauff N; Robson M; Kelly B; Barakat R; Satagopan J; Ellis N; Hensley M; Boyd J; Borgen P; Norton L; Offit K
J Clin Oncol; 2002 Mar; 20(5):1260-8. PubMed ID: 11870168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
